Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Plus Tenofovir vs Entecavir in Chronic Hepatitis B (BE-LOW)
NCT00410072Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of entecavir, tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Apr 2007; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00410072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410072.